A study published in the Annals of the Rheumatic Diseases looks at rates of uveitis acriss clinical trials of etanercept (Enbrel) in treating ankylosing spondylitis.

Researches found that, "In subjects with AS, rates of uveitis events with etanercept were lower than with placebo in placebo-controlled trials and similar to sulfasalazine in an active comparator trial."

To read the abstract click here.

STAY INFORMED! Stay up-to-date on all the latest news and information regarding AS and related diseases with our news magazine, Spondylitis Plus. Your subscription comes free with SAA membership, so click here to join today!